Immunohistochemistry cancer patients breast. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Breast Cell Line, Tumor Tumor Cells, Cultured Lymph Nodes Neoplastic Cells, Circulating Axilla MCF-7 Cells Epithelial Cells Neoplastic Stem Cells Mammary Glands, Human Prostate Nipples

Organisms4

Mice, Nude Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL

Diseases55

Carcinoma, Ductal, Breast Breast Neoplasms Neoplasms Breast Diseases Lung Neoplasms Neoplasm Metastasis Ovarian Neoplasms Neoplasm Invasiveness Prostatic Neoplasms Stomach Neoplasms Carcinoma Breast Neoplasms, Male Colorectal Neoplasms Colonic Neoplasms Adenocarcinoma Disease Progression Lymphatic Metastasis Neoplasm Recurrence, Local Pancreatic Neoplasms Genetic Predisposition to Disease Carcinoma, Lobular Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Carcinoma, Intraductal, Noninfiltrating Fibrocystic Breast Disease Uterine Cervical Neoplasms Bone Neoplasms Neoplastic Cells, Circulating Urinary Bladder Neoplasms Neoplasms, Hormone-Dependent Head and Neck Neoplasms Rectal Neoplasms Endometrial Neoplasms Neovascularization, Pathologic Cell Transformation, Neoplastic Mammary Neoplasms, Experimental Esophageal Neoplasms Disease Models, Animal Carcinoma in Situ Liver Neoplasms Carcinoma, Ductal Neoplasms, Second Primary Mouth Neoplasms Gastrointestinal Neoplasms Precancerous Conditions Fibroadenoma Genital Neoplasms, Female Neoplasms, Multiple Primary Fatigue Melanoma Neoplasms, Glandular and Epithelial Carcinoma, Small Cell Skin Neoplasms Triple Negative Breast Neoplasms Adenocarcinoma, Mucinous

Chemicals and Drugs54

Tumor Markers, Biological Receptors, Estrogen Receptor, erbB-2 Antineoplastic Agents Neoplasm Proteins RNA, Messenger Receptors, Progesterone Tamoxifen Antineoplastic Agents, Hormonal Fluorouracil Antigens, Neoplasm DNA, Neoplasm Antibodies, Monoclonal Cancer Vaccines Tumor Suppressor Protein p53 Ki-67 Antigen Receptor, Epidermal Growth Factor Antibodies, Monoclonal, Humanized Estrogen Receptor alpha RNA, Small Interfering BRCA2 Protein Antineoplastic Agents, Phytogenic Estrogens BRCA1 Protein Taxoids Cisplatin Cyclophosphamide Tumor Suppressor Proteins RNA, Neoplasm Mucin-1 Aromatase Inhibitors Epirubicin Carcinoembryonic Antigen Prostate-Specific Antigen DNA-Binding Proteins Estrogen Antagonists Paclitaxel Transcription Factors Vascular Endothelial Growth Factor A Antimetabolites, Antineoplastic Nuclear Proteins Keratins Proto-Oncogene Proteins Deoxycytidine Estradiol Nitriles DNA Primers MicroRNAs Cadherins Antibiotics, Antineoplastic Membrane Proteins Anticarcinogenic Agents Quinazolines Antibodies, Neoplasm

Analytical, Diagnostic and Therapeutic Techniques and Equipment79

Immunohistochemistry Prognosis Neoplasm Staging Reverse Transcriptase Polymerase Chain Reaction Survival Analysis Early Detection of Cancer Survival Rate Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Immunoenzyme Techniques Disease-Free Survival Chemotherapy, Adjuvant Mammography Blotting, Western Follow-Up Studies Treatment Outcome Gene Expression Profiling Mastectomy Prospective Studies Risk Factors Sensitivity and Specificity Tissue Array Analysis Kaplan-Meier Estimate Multivariate Analysis Case-Control Studies Polymerase Chain Reaction Predictive Value of Tests Risk Risk Assessment Breast Self-Examination Xenograft Model Antitumor Assays Reproducibility of Results Neoplasm Grading Oligonucleotide Array Sequence Analysis Registries Biopsy Neoplasm Transplantation Combined Modality Therapy Cohort Studies Odds Ratio Transplantation, Heterologous Questionnaires Breast Implants Radiotherapy In Situ Hybridization Tumor Burden In Situ Hybridization, Fluorescence Mastectomy, Segmental Incidence Mammary Neoplasms, Experimental Disease Models, Animal Enzyme-Linked Immunosorbent Assay Radiotherapy, Adjuvant SEER Program Clinical Trials as Topic Drug Administration Schedule Ultrasonography, Mammary Logistic Models Palliative Care DNA Mutational Analysis Biopsy, Needle Transfection Real-Time Polymerase Chain Reaction Lymph Node Excision Sentinel Lymph Node Biopsy Flow Cytometry Proportional Hazards Models Mammaplasty Molecular Targeted Therapy Paraffin Embedding Confidence Intervals Drug Screening Assays, Antitumor Neoadjuvant Therapy Pilot Projects Genetic Testing Models, Biological Immunotherapy Analysis of Variance Radiotherapy Dosage

Psychiatry and Psychology3

Breast Feeding Breast Self-Examination Smoking

Phenomena and Processes45

Gene Expression Regulation, Neoplastic Breast Feeding Drug Resistance, Neoplasm Genetic Predisposition to Disease Cell Proliferation Sensitivity and Specificity Time Factors Genes, BRCA1 Mutation Risk Apoptosis Up-Regulation Postmenopause Gene Expression Genes, erbB-2 Genotype DNA Methylation Odds Ratio Cell Movement Signal Transduction Down-Regulation Cell Division Germ-Line Mutation Premenopause Dose-Response Relationship, Drug Genes, BRCA2 Polymorphism, Genetic Menopause Gene Amplification Promoter Regions, Genetic Genes, p53 Phenotype Base Sequence Transfection Cell Growth Processes Cell Cycle RNA Interference Genes, Tumor Suppressor Cell Survival Genes, Neoplasm Gene Silencing Phosphorylation Loss of Heterozygosity Alleles Tissue Distribution

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Questionnaires Incidence SEER Program Base Sequence Molecular Sequence Data

Named Groups1

Health Care32

Survival Analysis Survival Rate Retrospective Studies Disease-Free Survival Follow-Up Studies Treatment Outcome Prospective Studies Risk Factors Sensitivity and Specificity Kaplan-Meier Estimate Multivariate Analysis Case-Control Studies Predictive Value of Tests Age Factors Risk Risk Assessment Reproducibility of Results Registries Cohort Studies Odds Ratio Questionnaires Incidence SEER Program Clinical Trials as Topic Logistic Models Palliative Care National Cancer Institute (U.S.)Proportional Hazards Models Confidence Intervals Pilot Projects Genetic Testing Analysis of Variance

Geographicals3

United States China Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Breast Immunohistochemistry Carcinoma, Ductal, Breast Breast Neoplasms Neoplasms Tumor Markers, Biological Breast Diseases Prognosis Neoplasm Staging Gene Expression Regulation, Neoplastic Lung Neoplasms Cell Line, Tumor Receptors, Estrogen Neoplasm Metastasis Receptor, erbB-2 Ovarian Neoplasms Neoplasm Invasiveness Antineoplastic Agents Prostatic Neoplasms Reverse Transcriptase Polymerase Chain Reaction Neoplasm Proteins RNA, Messenger Stomach Neoplasms Survival Analysis Receptors, Progesterone Tamoxifen Early Detection of Cancer Carcinoma Breast Neoplasms, Male Colorectal Neoplasms Survival Rate Antineoplastic Combined Chemotherapy Protocols Retrospective Studies Breast Feeding Immunoenzyme Techniques Disease-Free Survival Chemotherapy, Adjuvant Colonic Neoplasms Adenocarcinoma Mammography Blotting, Western Mice, Nude Disease Progression Antineoplastic Agents, Hormonal Follow-Up Studies Treatment Outcome Gene Expression Profiling Lymphatic Metastasis Neoplasm Recurrence, Local Drug Resistance, Neoplasm Mastectomy Prospective Studies Risk Factors Pancreatic Neoplasms Genetic Predisposition to Disease Cell Proliferation Carcinoma, Lobular Sensitivity and Specificity Carcinoma, Squamous Cell Fluorouracil Antigens, Neoplasm Tissue Array Analysis Kaplan-Meier Estimate DNA, Neoplasm Time Factors Tumor Cells, Cultured Genes, BRCA1 Multivariate Analysis Mutation Carcinoma, Non-Small-Cell Lung Case-Control Studies Antibodies, Monoclonal Polymerase Chain Reaction Carcinoma, Intraductal, Noninfiltrating Cancer Vaccines Fibrocystic Breast Disease Predictive Value of Tests Age Factors Tumor Suppressor Protein p53 Risk Apoptosis Uterine Cervical Neoplasms Ki-67 Antigen Bone Neoplasms Risk Assessment Lymph Nodes Breast Self-Examination Neoplastic Cells, Circulating Xenograft Model Antitumor Assays Up-Regulation Reproducibility of Results Postmenopause Neoplasm Grading Gene Expression Oligonucleotide Array Sequence Analysis Urinary Bladder Neoplasms Survivors Registries Biopsy Medical Oncology

No FAQ available that match "immunohistochemistry cancer patients breast"